Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Dow
Merck
Colorcon
Julphar
Express Scripts
Covington
Medtronic
US Army
Citi

Generated: January 16, 2018

DrugPatentWatch Database Preview

Boscogen Company Profile

« Back to Dashboard

What is the competitive landscape for BOSCOGEN, and what generic and branded alternatives to BOSCOGEN drugs are available?

BOSCOGEN has four approved drugs.



Summary for Boscogen
US Patents:0
Tradenames:4
Ingredients:4
NDAs:4

Drugs and US Patents for Boscogen

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boscogen REPAGLINIDE repaglinide TABLET;ORAL 091517-002 Apr 24, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Boscogen SELEGILINE HYDROCHLORIDE selegiline hydrochloride TABLET;ORAL 074912-001 Apr 30, 1998 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Boscogen CAPTOPRIL captopril TABLET;ORAL 074677-002 May 30, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Boscogen CAPTOPRIL captopril TABLET;ORAL 074677-003 May 30, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Boscogen CAPTOPRIL captopril TABLET;ORAL 074677-004 May 30, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Boscogen REPAGLINIDE repaglinide TABLET;ORAL 091517-001 Apr 24, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Boscogen CAPTOPRIL captopril TABLET;ORAL 074677-001 May 30, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Boscogen REPAGLINIDE repaglinide TABLET;ORAL 091517-003 Apr 24, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Boscogen ACYCLOVIR acyclovir CAPSULE;ORAL 075090-001 Jan 26, 1999 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Covington
AstraZeneca
Boehringer Ingelheim
Merck
Harvard Business School
Cipla
Argus Health
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot